tiprankstipranks
MediciNova to support NIH-funded EAP trial to evaluate MN166 in ALS
PremiumThe FlyMediciNova to support NIH-funded EAP trial to evaluate MN166 in ALS
2M ago
MediciNova says abstract regarding MN-166 accepted for poster presentation
Premium
The Fly
MediciNova says abstract regarding MN-166 accepted for poster presentation
3M ago
MediciNova announces notice of allowance from USPTO for MN-166
Premium
The Fly
MediciNova announces notice of allowance from USPTO for MN-166
6M ago
MediciNova Vice President Geoffrey O’Brien Announces Retirement
PremiumCompany AnnouncementsMediciNova Vice President Geoffrey O’Brien Announces Retirement
8M ago
MediciNova gets notice of allowance from Japan for pending patent for MN-166
Premium
The Fly
MediciNova gets notice of allowance from Japan for pending patent for MN-166
8M ago
MediciNova’s two abstrats regarding MN-001 and MN-002 accepted at EAS
Premium
The Fly
MediciNova’s two abstrats regarding MN-001 and MN-002 accepted at EAS
8M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
1y ago
MediciNova announces new data, results of Phase 2 trial of MN-166 in GBM
Premium
The Fly
MediciNova announces new data, results of Phase 2 trial of MN-166 in GBM
1y ago
MediciNova discloses notice of allowance for new patent on MN-166 + Riluzole
Premium
The Fly
MediciNova discloses notice of allowance for new patent on MN-166 + Riluzole
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100